nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Pollakiuria—Paclitaxel—kidney cancer	0.00346	0.00346	CcSEcCtD
Dimenhydrinate—Asthenia—Pazopanib—kidney cancer	0.00345	0.00345	CcSEcCtD
Dimenhydrinate—Insomnia—Everolimus—kidney cancer	0.00343	0.00343	CcSEcCtD
Dimenhydrinate—Paraesthesia—Vinblastine—kidney cancer	0.00342	0.00342	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00341	0.00341	CcSEcCtD
Dimenhydrinate—Paraesthesia—Everolimus—kidney cancer	0.0034	0.0034	CcSEcCtD
Dimenhydrinate—Irritability—Capecitabine—kidney cancer	0.00339	0.00339	CcSEcCtD
Dimenhydrinate—Urinary retention—Capecitabine—kidney cancer	0.00338	0.00338	CcSEcCtD
Dimenhydrinate—Somnolence—Everolimus—kidney cancer	0.00337	0.00337	CcSEcCtD
Dimenhydrinate—Dizziness—Temsirolimus—kidney cancer	0.00337	0.00337	CcSEcCtD
Dimenhydrinate—Convulsion—Sunitinib—kidney cancer	0.00336	0.00336	CcSEcCtD
Dimenhydrinate—Dry mouth—Sorafenib—kidney cancer	0.00336	0.00336	CcSEcCtD
Dimenhydrinate—Dyspepsia—Everolimus—kidney cancer	0.00334	0.00334	CcSEcCtD
Dimenhydrinate—Insomnia—Erlotinib—kidney cancer	0.00331	0.00331	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vinblastine—kidney cancer	0.00331	0.00331	CcSEcCtD
Dimenhydrinate—Decreased appetite—Everolimus—kidney cancer	0.0033	0.0033	CcSEcCtD
Dimenhydrinate—Diarrhoea—Pazopanib—kidney cancer	0.00329	0.00329	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Paclitaxel—kidney cancer	0.00327	0.00327	CcSEcCtD
Dimenhydrinate—Fatigue—Everolimus—kidney cancer	0.00327	0.00327	CcSEcCtD
Dimenhydrinate—Constipation—Vinblastine—kidney cancer	0.00325	0.00325	CcSEcCtD
Dimenhydrinate—Constipation—Everolimus—kidney cancer	0.00324	0.00324	CcSEcCtD
Dimenhydrinate—Vomiting—Temsirolimus—kidney cancer	0.00324	0.00324	CcSEcCtD
Dimenhydrinate—Dry mouth—Sunitinib—kidney cancer	0.00323	0.00323	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Sorafenib—kidney cancer	0.00322	0.00322	CcSEcCtD
Dimenhydrinate—Dyspepsia—Erlotinib—kidney cancer	0.00322	0.00322	CcSEcCtD
Dimenhydrinate—Rash—Temsirolimus—kidney cancer	0.00321	0.00321	CcSEcCtD
Dimenhydrinate—Dermatitis—Temsirolimus—kidney cancer	0.00321	0.00321	CcSEcCtD
Dimenhydrinate—Chills—Gemcitabine—kidney cancer	0.00321	0.00321	CcSEcCtD
Dimenhydrinate—Headache—Temsirolimus—kidney cancer	0.00319	0.00319	CcSEcCtD
Dimenhydrinate—Decreased appetite—Erlotinib—kidney cancer	0.00318	0.00318	CcSEcCtD
Dimenhydrinate—Dizziness—Pazopanib—kidney cancer	0.00318	0.00318	CcSEcCtD
Dimenhydrinate—Fatigue—Erlotinib—kidney cancer	0.00315	0.00315	CcSEcCtD
Dimenhydrinate—Anorexia—Sorafenib—kidney cancer	0.00314	0.00314	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Vinblastine—kidney cancer	0.00314	0.00314	CcSEcCtD
Dimenhydrinate—Constipation—Erlotinib—kidney cancer	0.00313	0.00313	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Everolimus—kidney cancer	0.00312	0.00312	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Sunitinib—kidney cancer	0.0031	0.0031	CcSEcCtD
Dimenhydrinate—Vomiting—Pazopanib—kidney cancer	0.00305	0.00305	CcSEcCtD
Dimenhydrinate—Rash—Pazopanib—kidney cancer	0.00303	0.00303	CcSEcCtD
Dimenhydrinate—Nausea—Temsirolimus—kidney cancer	0.00303	0.00303	CcSEcCtD
Dimenhydrinate—Dermatitis—Pazopanib—kidney cancer	0.00302	0.00302	CcSEcCtD
Dimenhydrinate—Anorexia—Sunitinib—kidney cancer	0.00302	0.00302	CcSEcCtD
Dimenhydrinate—Agitation—Vincristine—kidney cancer	0.00302	0.00302	CcSEcCtD
Dimenhydrinate—Headache—Pazopanib—kidney cancer	0.00301	0.00301	CcSEcCtD
Dimenhydrinate—Sweating increased—Capecitabine—kidney cancer	0.00299	0.00299	CcSEcCtD
Dimenhydrinate—Vertigo—Vincristine—kidney cancer	0.00295	0.00295	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Dactinomycin—kidney cancer	0.00294	0.00294	CcSEcCtD
Dimenhydrinate—Dyspepsia—Sorafenib—kidney cancer	0.0029	0.0029	CcSEcCtD
Dimenhydrinate—Dysuria—Capecitabine—kidney cancer	0.00287	0.00287	CcSEcCtD
Dimenhydrinate—Insomnia—Sunitinib—kidney cancer	0.00286	0.00286	CcSEcCtD
Dimenhydrinate—Decreased appetite—Sorafenib—kidney cancer	0.00286	0.00286	CcSEcCtD
Dimenhydrinate—Anorexia—Dactinomycin—kidney cancer	0.00286	0.00286	CcSEcCtD
Dimenhydrinate—Nausea—Pazopanib—kidney cancer	0.00285	0.00285	CcSEcCtD
Dimenhydrinate—Paraesthesia—Sunitinib—kidney cancer	0.00284	0.00284	CcSEcCtD
Dimenhydrinate—Convulsion—Vincristine—kidney cancer	0.00284	0.00284	CcSEcCtD
Dimenhydrinate—Fatigue—Sorafenib—kidney cancer	0.00284	0.00284	CcSEcCtD
Dimenhydrinate—Constipation—Sorafenib—kidney cancer	0.00281	0.00281	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Capecitabine—kidney cancer	0.0028	0.0028	CcSEcCtD
Dimenhydrinate—Tinnitus—Paclitaxel—kidney cancer	0.00279	0.00279	CcSEcCtD
Dimenhydrinate—Dyspepsia—Sunitinib—kidney cancer	0.00279	0.00279	CcSEcCtD
Dimenhydrinate—Decreased appetite—Sunitinib—kidney cancer	0.00275	0.00275	CcSEcCtD
Dimenhydrinate—Asthenia—Vinblastine—kidney cancer	0.00273	0.00273	CcSEcCtD
Dimenhydrinate—Fatigue—Sunitinib—kidney cancer	0.00273	0.00273	CcSEcCtD
Dimenhydrinate—Asthenia—Everolimus—kidney cancer	0.00272	0.00272	CcSEcCtD
Dimenhydrinate—Constipation—Sunitinib—kidney cancer	0.00271	0.00271	CcSEcCtD
Dimenhydrinate—Chills—Paclitaxel—kidney cancer	0.00269	0.00269	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Capecitabine—kidney cancer	0.00268	0.00268	CcSEcCtD
Dimenhydrinate—Asthenia—Erlotinib—kidney cancer	0.00262	0.00262	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Vincristine—kidney cancer	0.00262	0.00262	CcSEcCtD
Dimenhydrinate—Urticaria—Sorafenib—kidney cancer	0.00261	0.00261	CcSEcCtD
Dimenhydrinate—Photosensitivity—Doxorubicin—kidney cancer	0.00261	0.00261	CcSEcCtD
Dimenhydrinate—Decreased appetite—Dactinomycin—kidney cancer	0.00261	0.00261	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vinblastine—kidney cancer	0.0026	0.0026	CcSEcCtD
Dimenhydrinate—Diarrhoea—Everolimus—kidney cancer	0.00259	0.00259	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Vincristine—kidney cancer	0.00259	0.00259	CcSEcCtD
Dimenhydrinate—Fatigue—Dactinomycin—kidney cancer	0.00258	0.00258	CcSEcCtD
Dimenhydrinate—Tension—Paclitaxel—kidney cancer	0.00256	0.00256	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Capecitabine—kidney cancer	0.00255	0.00255	CcSEcCtD
Dimenhydrinate—Anorexia—Vincristine—kidney cancer	0.00255	0.00255	CcSEcCtD
Dimenhydrinate—Nervousness—Paclitaxel—kidney cancer	0.00253	0.00253	CcSEcCtD
Dimenhydrinate—Dizziness—Vinblastine—kidney cancer	0.00252	0.00252	CcSEcCtD
Dimenhydrinate—Dizziness—Everolimus—kidney cancer	0.00251	0.00251	CcSEcCtD
Dimenhydrinate—Diarrhoea—Erlotinib—kidney cancer	0.0025	0.0025	CcSEcCtD
Dimenhydrinate—Hypotension—Vincristine—kidney cancer	0.0025	0.0025	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Gemcitabine—kidney cancer	0.00249	0.00249	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Dactinomycin—kidney cancer	0.00247	0.00247	CcSEcCtD
Dimenhydrinate—Vision blurred—Paclitaxel—kidney cancer	0.00246	0.00246	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Gemcitabine—kidney cancer	0.00246	0.00246	CcSEcCtD
Dimenhydrinate—Tremor—Paclitaxel—kidney cancer	0.00244	0.00244	CcSEcCtD
Dimenhydrinate—Insomnia—Vincristine—kidney cancer	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Anorexia—Gemcitabine—kidney cancer	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Vomiting—Vinblastine—kidney cancer	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Dizziness—Erlotinib—kidney cancer	0.00242	0.00242	CcSEcCtD
Dimenhydrinate—Vomiting—Everolimus—kidney cancer	0.00241	0.00241	CcSEcCtD
Dimenhydrinate—Paraesthesia—Vincristine—kidney cancer	0.00241	0.00241	CcSEcCtD
Dimenhydrinate—Agitation—Paclitaxel—kidney cancer	0.0024	0.0024	CcSEcCtD
Dimenhydrinate—Rash—Everolimus—kidney cancer	0.00239	0.00239	CcSEcCtD
Dimenhydrinate—Dermatitis—Everolimus—kidney cancer	0.00239	0.00239	CcSEcCtD
Dimenhydrinate—Headache—Vinblastine—kidney cancer	0.00238	0.00238	CcSEcCtD
Dimenhydrinate—Headache—Everolimus—kidney cancer	0.00238	0.00238	CcSEcCtD
Dimenhydrinate—Hypotension—Gemcitabine—kidney cancer	0.00237	0.00237	CcSEcCtD
Dimenhydrinate—Asthenia—Sorafenib—kidney cancer	0.00236	0.00236	CcSEcCtD
Dimenhydrinate—Vertigo—Paclitaxel—kidney cancer	0.00234	0.00234	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vincristine—kidney cancer	0.00233	0.00233	CcSEcCtD
Dimenhydrinate—Vomiting—Erlotinib—kidney cancer	0.00233	0.00233	CcSEcCtD
Dimenhydrinate—Fatigue—Vincristine—kidney cancer	0.00231	0.00231	CcSEcCtD
Dimenhydrinate—Rash—Erlotinib—kidney cancer	0.00231	0.00231	CcSEcCtD
Dimenhydrinate—Dermatitis—Erlotinib—kidney cancer	0.0023	0.0023	CcSEcCtD
Dimenhydrinate—Palpitations—Paclitaxel—kidney cancer	0.0023	0.0023	CcSEcCtD
Dimenhydrinate—Insomnia—Gemcitabine—kidney cancer	0.0023	0.0023	CcSEcCtD
Dimenhydrinate—Headache—Erlotinib—kidney cancer	0.00229	0.00229	CcSEcCtD
Dimenhydrinate—Tinnitus—Capecitabine—kidney cancer	0.00229	0.00229	CcSEcCtD
Dimenhydrinate—Constipation—Vincristine—kidney cancer	0.00229	0.00229	CcSEcCtD
Dimenhydrinate—Diplopia—Doxorubicin—kidney cancer	0.00229	0.00229	CcSEcCtD
Dimenhydrinate—Paraesthesia—Gemcitabine—kidney cancer	0.00228	0.00228	CcSEcCtD
Dimenhydrinate—Asthenia—Sunitinib—kidney cancer	0.00227	0.00227	CcSEcCtD
Dimenhydrinate—Nausea—Vinblastine—kidney cancer	0.00226	0.00226	CcSEcCtD
Dimenhydrinate—Somnolence—Gemcitabine—kidney cancer	0.00226	0.00226	CcSEcCtD
Dimenhydrinate—Convulsion—Paclitaxel—kidney cancer	0.00226	0.00226	CcSEcCtD
Dimenhydrinate—Nausea—Everolimus—kidney cancer	0.00225	0.00225	CcSEcCtD
Dimenhydrinate—Diarrhoea—Sorafenib—kidney cancer	0.00225	0.00225	CcSEcCtD
Dimenhydrinate—Decreased appetite—Gemcitabine—kidney cancer	0.00221	0.00221	CcSEcCtD
Dimenhydrinate—Chills—Capecitabine—kidney cancer	0.0022	0.0022	CcSEcCtD
Dimenhydrinate—Fatigue—Gemcitabine—kidney cancer	0.00219	0.00219	CcSEcCtD
Dimenhydrinate—Dizziness—Sorafenib—kidney cancer	0.00218	0.00218	CcSEcCtD
Dimenhydrinate—Constipation—Gemcitabine—kidney cancer	0.00217	0.00217	CcSEcCtD
Dimenhydrinate—Nausea—Erlotinib—kidney cancer	0.00217	0.00217	CcSEcCtD
Dimenhydrinate—Dry mouth—Paclitaxel—kidney cancer	0.00217	0.00217	CcSEcCtD
Dimenhydrinate—Diarrhoea—Sunitinib—kidney cancer	0.00217	0.00217	CcSEcCtD
Dimenhydrinate—Asthenia—Dactinomycin—kidney cancer	0.00215	0.00215	CcSEcCtD
Dimenhydrinate—Confusional state—Paclitaxel—kidney cancer	0.00215	0.00215	CcSEcCtD
Dimenhydrinate—Dizziness—Sunitinib—kidney cancer	0.00209	0.00209	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Gemcitabine—kidney cancer	0.00209	0.00209	CcSEcCtD
Dimenhydrinate—Vomiting—Sorafenib—kidney cancer	0.00209	0.00209	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Paclitaxel—kidney cancer	0.00208	0.00208	CcSEcCtD
Dimenhydrinate—Tachycardia—Paclitaxel—kidney cancer	0.00208	0.00208	CcSEcCtD
Dimenhydrinate—Rash—Sorafenib—kidney cancer	0.00208	0.00208	CcSEcCtD
Dimenhydrinate—Dermatitis—Sorafenib—kidney cancer	0.00207	0.00207	CcSEcCtD
Dimenhydrinate—Headache—Sorafenib—kidney cancer	0.00206	0.00206	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Paclitaxel—kidney cancer	0.00206	0.00206	CcSEcCtD
Dimenhydrinate—Diarrhoea—Dactinomycin—kidney cancer	0.00205	0.00205	CcSEcCtD
Dimenhydrinate—Anorexia—Paclitaxel—kidney cancer	0.00203	0.00203	CcSEcCtD
Dimenhydrinate—Vision blurred—Capecitabine—kidney cancer	0.00202	0.00202	CcSEcCtD
Dimenhydrinate—Vomiting—Sunitinib—kidney cancer	0.00201	0.00201	CcSEcCtD
Dimenhydrinate—Tremor—Capecitabine—kidney cancer	0.002	0.002	CcSEcCtD
Dimenhydrinate—Rash—Sunitinib—kidney cancer	0.002	0.002	CcSEcCtD
Dimenhydrinate—Dermatitis—Sunitinib—kidney cancer	0.00199	0.00199	CcSEcCtD
Dimenhydrinate—Hypotension—Paclitaxel—kidney cancer	0.00199	0.00199	CcSEcCtD
Dimenhydrinate—Headache—Sunitinib—kidney cancer	0.00198	0.00198	CcSEcCtD
Dimenhydrinate—Nausea—Sorafenib—kidney cancer	0.00195	0.00195	CcSEcCtD
Dimenhydrinate—Insomnia—Paclitaxel—kidney cancer	0.00192	0.00192	CcSEcCtD
Dimenhydrinate—Vertigo—Capecitabine—kidney cancer	0.00192	0.00192	CcSEcCtD
Dimenhydrinate—Asthenia—Vincristine—kidney cancer	0.00192	0.00192	CcSEcCtD
Dimenhydrinate—Paraesthesia—Paclitaxel—kidney cancer	0.00191	0.00191	CcSEcCtD
Dimenhydrinate—Vomiting—Dactinomycin—kidney cancer	0.00191	0.00191	CcSEcCtD
Dimenhydrinate—Somnolence—Paclitaxel—kidney cancer	0.00189	0.00189	CcSEcCtD
Dimenhydrinate—Palpitations—Capecitabine—kidney cancer	0.00189	0.00189	CcSEcCtD
Dimenhydrinate—Rash—Dactinomycin—kidney cancer	0.00189	0.00189	CcSEcCtD
Dimenhydrinate—Nausea—Sunitinib—kidney cancer	0.00188	0.00188	CcSEcCtD
Dimenhydrinate—Dyspepsia—Paclitaxel—kidney cancer	0.00187	0.00187	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—kidney cancer	0.00185	0.00185	CcSEcCtD
Dimenhydrinate—Decreased appetite—Paclitaxel—kidney cancer	0.00185	0.00185	CcSEcCtD
Dimenhydrinate—Fatigue—Paclitaxel—kidney cancer	0.00183	0.00183	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vincristine—kidney cancer	0.00183	0.00183	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—kidney cancer	0.00183	0.00183	CcSEcCtD
Dimenhydrinate—Asthenia—Gemcitabine—kidney cancer	0.00182	0.00182	CcSEcCtD
Dimenhydrinate—Constipation—Paclitaxel—kidney cancer	0.00182	0.00182	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00181	0.00181	CcSEcCtD
Dimenhydrinate—Dry mouth—Capecitabine—kidney cancer	0.00178	0.00178	CcSEcCtD
Dimenhydrinate—Nausea—Dactinomycin—kidney cancer	0.00178	0.00178	CcSEcCtD
Dimenhydrinate—Dizziness—Vincristine—kidney cancer	0.00177	0.00177	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—kidney cancer	0.00176	0.00176	CcSEcCtD
Dimenhydrinate—Confusional state—Capecitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Paclitaxel—kidney cancer	0.00175	0.00175	CcSEcCtD
Dimenhydrinate—Diarrhoea—Gemcitabine—kidney cancer	0.00174	0.00174	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—kidney cancer	0.00173	0.00173	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Capecitabine—kidney cancer	0.00171	0.00171	CcSEcCtD
Dimenhydrinate—Tachycardia—Capecitabine—kidney cancer	0.0017	0.0017	CcSEcCtD
Dimenhydrinate—Vomiting—Vincristine—kidney cancer	0.0017	0.0017	CcSEcCtD
Dimenhydrinate—Urticaria—Paclitaxel—kidney cancer	0.00169	0.00169	CcSEcCtD
Dimenhydrinate—Rash—Vincristine—kidney cancer	0.00169	0.00169	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Capecitabine—kidney cancer	0.00169	0.00169	CcSEcCtD
Dimenhydrinate—Dermatitis—Vincristine—kidney cancer	0.00169	0.00169	CcSEcCtD
Dimenhydrinate—Headache—Vincristine—kidney cancer	0.00168	0.00168	CcSEcCtD
Dimenhydrinate—Anorexia—Capecitabine—kidney cancer	0.00166	0.00166	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—kidney cancer	0.00165	0.00165	CcSEcCtD
Dimenhydrinate—Hypotension—Capecitabine—kidney cancer	0.00163	0.00163	CcSEcCtD
Dimenhydrinate—Vomiting—Gemcitabine—kidney cancer	0.00162	0.00162	CcSEcCtD
Dimenhydrinate—Rash—Gemcitabine—kidney cancer	0.0016	0.0016	CcSEcCtD
Dimenhydrinate—Dermatitis—Gemcitabine—kidney cancer	0.0016	0.0016	CcSEcCtD
Dimenhydrinate—Headache—Gemcitabine—kidney cancer	0.00159	0.00159	CcSEcCtD
Dimenhydrinate—Nausea—Vincristine—kidney cancer	0.00159	0.00159	CcSEcCtD
Dimenhydrinate—Insomnia—Capecitabine—kidney cancer	0.00158	0.00158	CcSEcCtD
Dimenhydrinate—Paraesthesia—Capecitabine—kidney cancer	0.00157	0.00157	CcSEcCtD
Dimenhydrinate—Dyspepsia—Capecitabine—kidney cancer	0.00154	0.00154	CcSEcCtD
Dimenhydrinate—Asthenia—Paclitaxel—kidney cancer	0.00153	0.00153	CcSEcCtD
Dimenhydrinate—Decreased appetite—Capecitabine—kidney cancer	0.00152	0.00152	CcSEcCtD
Dimenhydrinate—Nausea—Gemcitabine—kidney cancer	0.00151	0.00151	CcSEcCtD
Dimenhydrinate—Fatigue—Capecitabine—kidney cancer	0.00151	0.00151	CcSEcCtD
Dimenhydrinate—Constipation—Capecitabine—kidney cancer	0.00149	0.00149	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—kidney cancer	0.00148	0.00148	CcSEcCtD
Dimenhydrinate—Diarrhoea—Paclitaxel—kidney cancer	0.00146	0.00146	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Capecitabine—kidney cancer	0.00144	0.00144	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—kidney cancer	0.00142	0.00142	CcSEcCtD
Dimenhydrinate—Dizziness—Paclitaxel—kidney cancer	0.00141	0.00141	CcSEcCtD
Dimenhydrinate—Urticaria—Capecitabine—kidney cancer	0.00139	0.00139	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—kidney cancer	0.00135	0.00135	CcSEcCtD
Dimenhydrinate—Vomiting—Paclitaxel—kidney cancer	0.00135	0.00135	CcSEcCtD
Dimenhydrinate—Rash—Paclitaxel—kidney cancer	0.00134	0.00134	CcSEcCtD
Dimenhydrinate—Dermatitis—Paclitaxel—kidney cancer	0.00134	0.00134	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Dimenhydrinate—Headache—Paclitaxel—kidney cancer	0.00133	0.00133	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—kidney cancer	0.0013	0.0013	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—kidney cancer	0.00127	0.00127	CcSEcCtD
Dimenhydrinate—Nausea—Paclitaxel—kidney cancer	0.00126	0.00126	CcSEcCtD
Dimenhydrinate—Asthenia—Capecitabine—kidney cancer	0.00125	0.00125	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—kidney cancer	0.00124	0.00124	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—kidney cancer	0.00122	0.00122	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—kidney cancer	0.00119	0.00119	CcSEcCtD
Dimenhydrinate—Diarrhoea—Capecitabine—kidney cancer	0.00119	0.00119	CcSEcCtD
Dimenhydrinate—Dizziness—Capecitabine—kidney cancer	0.00115	0.00115	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—kidney cancer	0.00115	0.00115	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—kidney cancer	0.00113	0.00113	CcSEcCtD
Dimenhydrinate—Vomiting—Capecitabine—kidney cancer	0.00111	0.00111	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—kidney cancer	0.0011	0.0011	CcSEcCtD
Dimenhydrinate—Rash—Capecitabine—kidney cancer	0.0011	0.0011	CcSEcCtD
Dimenhydrinate—Dermatitis—Capecitabine—kidney cancer	0.0011	0.0011	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—kidney cancer	0.0011	0.0011	CcSEcCtD
Dimenhydrinate—Headache—Capecitabine—kidney cancer	0.00109	0.00109	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—kidney cancer	0.00109	0.00109	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—kidney cancer	0.00107	0.00107	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—kidney cancer	0.00105	0.00105	CcSEcCtD
Dimenhydrinate—Nausea—Capecitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—kidney cancer	0.00102	0.00102	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—kidney cancer	0.00101	0.00101	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—kidney cancer	0.001	0.001	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—kidney cancer	0.000991	0.000991	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—kidney cancer	0.000978	0.000978	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—kidney cancer	0.00097	0.00097	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—kidney cancer	0.000962	0.000962	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—kidney cancer	0.000927	0.000927	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—kidney cancer	0.000894	0.000894	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—kidney cancer	0.000807	0.000807	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—kidney cancer	0.00077	0.00077	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—kidney cancer	0.000744	0.000744	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—kidney cancer	0.000716	0.000716	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—kidney cancer	0.00071	0.00071	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—kidney cancer	0.000709	0.000709	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—kidney cancer	0.000705	0.000705	CcSEcCtD
Dimenhydrinate—Nausea—Doxorubicin—kidney cancer	0.000668	0.000668	CcSEcCtD
